| pubmed-article:19121783 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:19121783 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:19121783 | lifeskim:mentions | umls-concept:C0948265 | lld:lifeskim |
| pubmed-article:19121783 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:19121783 | pubmed:dateCreated | 2009-1-5 | lld:pubmed |
| pubmed-article:19121783 | pubmed:abstractText | Metabolic syndrome (MS) can be linked to the progression of chronic renal transplant dysfunction (CRTD). Hyperfiltration in transplanted patients is a further risk factor for MS and for the progression of CRTD. Many studies show in kidney-transplanted subjects a prevalence of MS at 60% after 6 years posttransplantation. We studied 182 patients (126 men and 56 women) with functioning renal transplant in Messina and Rovigo Renal Units. In our patients we saw at 6 years postkidney transplant in men a prevalence of MS at 20% (NCEPATPIII criteria) or 30% (Rovigo-Messina more strict criteria), and women at 6 years posttransplantation a prevalence of MS at 25% (NCEPATPIII criteria) or 50% (Rovigo-Messina criteria). In our patients, the period of graft function was over 15 years. This result is due to continued follow-up of metabolic parameters and to moderate protein (0.8-0.9 g/kg/day), low lipid, and low caloric intake. These strategies permit the avoidance of hyperfiltration, the reduction of hyperlipidemia and obesity. Special attention is due to women 50-65 years old. In these patients the prevalence of metabolic syndrome 6 years posttransplant is very high (60%). Postmenopausal syndrome is an additional risk factor for MS, atherosclerosis, and the progression of CRTD. | lld:pubmed |
| pubmed-article:19121783 | pubmed:language | eng | lld:pubmed |
| pubmed-article:19121783 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:19121783 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:19121783 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:19121783 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:19121783 | pubmed:issn | 1532-8503 | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:SantoroDomeni... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:PatiTeclaT | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:BellinghieriG... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:SavicaVincenz... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:BernardiAnnam... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:PivaMicheleM | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:BuccianteGius... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:ScaramuzzoPao... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:StoppaFabrizi... | lld:pubmed |
| pubmed-article:19121783 | pubmed:author | pubmed-author:GarizzoOdinoO | lld:pubmed |
| pubmed-article:19121783 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:19121783 | pubmed:volume | 19 | lld:pubmed |
| pubmed-article:19121783 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:19121783 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:19121783 | pubmed:pagination | 105-10 | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:meshHeading | pubmed-meshheading:19121783... | lld:pubmed |
| pubmed-article:19121783 | pubmed:year | 2009 | lld:pubmed |
| pubmed-article:19121783 | pubmed:articleTitle | Metabolic syndrome after kidney transplantation. | lld:pubmed |
| pubmed-article:19121783 | pubmed:affiliation | Cattedra di Nefrologia, Università di Messina, SOC di Nefrologia-Nutrizione Clinica ULSS 18 Rovigo, Italy. | lld:pubmed |
| pubmed-article:19121783 | pubmed:publicationType | Journal Article | lld:pubmed |
